Heron Therapeutics Inc vs Global X Robo Global Robotics & Automation ETF — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Global X Robo Global Robotics & Automation ETF trades at $79.08. The key difference: Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | ROBO | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.96 | $90.34 |
52-Week Low | $0.39 | $61.34 |
Enterprise Value | $189.36M | — |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
ROBO Global Robotics and Automation Index ETF trades at $77.31, down 0.74% with a bearish technical signal from moving averages. The ETF provides diversified exposure to robotics and AI themes with 79 holdings across machinery and electronic equipment sectors. Recent index rebalancing has shifted weight toward AI infrastructure and physical automation themes, reflecting evolving technology trends.
The ETF offers growth exposure to the expanding physical AI ecosystem but faces cyclical risks from industrial markets. While thematic positioning remains relevant, valuation concerns exist with a 24.9x P/E ratio. Key catalysts include AI infrastructure development and reshoring trends, though competition and market volatility present ongoing challenges.
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →